BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 15386362)

  • 21. A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
    Lee Y; Miron A; Drapkin R; Nucci MR; Medeiros F; Saleemuddin A; Garber J; Birch C; Mou H; Gordon RW; Cramer DW; McKeon FD; Crum CP
    J Pathol; 2007 Jan; 211(1):26-35. PubMed ID: 17117391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 mutations and expression in breast carcinoma in situ.
    Lukas J; Niu N; Press MF
    Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 gene alternation in squamous cell carcinoma of the esophagus detected by PCR-cold SSCP analysis.
    Wang LS; Chow KC; Liu CC; Chiu JH
    Proc Natl Sci Counc Repub China B; 1998 Jul; 22(3):114-21. PubMed ID: 9779600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of p53 protein expression in growth pattern of esophageal squamous cell carcinoma.
    Nozoe T; Kuwano H; Toh Y; Watanabe M; Kitamura M; Sugimachi K
    Oncol Rep; 1998; 5(5):1119-23. PubMed ID: 9683820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
    Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation of p53 in esophageal squamous cell carcinoma.
    Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Kise Y; Kenmochi T; Himeno S; Machimura T; Tanaka M; Inokuchi S; Tajima T; Osamura RY; Makuuchi H
    Int J Mol Med; 2001 Oct; 8(4):359-63. PubMed ID: 11562772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations.
    Coggi G; Bosari S; Roncalli M; Graziani D; Bossi P; Viale G; Buffa R; Ferrero S; Piazza M; Blandamura S; Segalin A; Bonavina L; Peracchia A
    Cancer; 1997 Feb; 79(3):425-32. PubMed ID: 9028350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
    Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
    Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis.
    Kitamura A; Yashima K; Okamoto E; Andachi H; Hosoda A; Kishimoto Y; Shiota G; Ito H; Kaibara N; Kawasaki H
    Oncology; 2001; 61(3):205-11. PubMed ID: 11574776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of p53 gene mutations in human esophageal squamous cell carcinomas using a p53 yeast functional assay: possible difference in esophageal carcinogenesis between the young and the elderly group.
    Okuda E; Osugi H; Morimura K; Takada N; Takemura M; Fukushima S; Higashino M; Kinoshita H
    Clin Cancer Res; 2001 Mar; 7(3):600-6. PubMed ID: 11297255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
    Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
    Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma.
    Pinto AP; Miron A; Yassin Y; Monte N; Woo TY; Mehra KK; Medeiros F; Crum CP
    Mod Pathol; 2010 Mar; 23(3):404-12. PubMed ID: 20062014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients.
    Lam KY; Law S; Tin L; Tung PH; Wong J
    Am J Gastroenterol; 1999 Aug; 94(8):2060-8. PubMed ID: 10445528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.
    Cao W; Chen X; Dai H; Wang H; Shen B; Chu D; McAfee T; Zhang ZF
    Cancer; 2004 Aug; 101(4):834-44. PubMed ID: 15305417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
    Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated p53 histopathologic/genetic analysis of premalignant lesions of the esophagus.
    Safatle-Ribeiro AV; Ribeiro U; Sakai P; Clarke MR; Fylyk SN; Ishioka S; Gama-Rodrigues J; Finkelstein SD; Reynolds JC
    Cancer Detect Prev; 2000; 24(1):13-23. PubMed ID: 10757119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis.
    Geddert H; Kiel S; Heep HJ; Gabbert HE; Sarbia M
    Hum Pathol; 2003 Sep; 34(9):850-6. PubMed ID: 14562279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history.
    Bennett WP; von Brevern MC; Zhu SM; Bartsch H; Muehlbauer KR; Hollstein MC
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):963-6. PubMed ID: 9367071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laser pressure catapulting (LPC): optimization LPC-system and genotyping of colorectal carcinomas.
    Bazan V; La Rocca G; Corsale S; Agnese V; Macaluso M; Migliavacca M; Gregorio V; Cascio S; Sisto PS; Di Fede G; Buscemi M; Fiorentino E; Passantino R; Morello V; Tomasino RM; Russo A
    J Cell Physiol; 2005 Feb; 202(2):503-9. PubMed ID: 15316933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.